SHSrinivas Hebbar

Srinivas Hebbar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Srinivas Hebbar has a total of 76 co-authors. Here are the top co-authors by number of shared publications:

  • Akhilesh Dubey

    Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Mangalore, India

    6 shared publications
  • Akhilesh Dubey

    Department of Pharmaceutics, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Deralakatte, Mangalore, Karnataka, 575018

    4 shared publications
  • Amitha Shetty

    Department of Pharmaceutics, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Deralakatte, Mangalore, Karnataka, 575018

    3 shared publications
  • Anup Naha

    Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India

    3 shared publications
  • Anup Naha

    Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India

    3 shared publications
  • Induja Govindan

    Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, India

    3 shared publications

Latest Publications

  • Open Access

    Global research landscape on herbal, traditional, and complementary therapies for psoriasis: a global bibliometric analysis (2005–2025)

    by Suresh Govindasamy, Yogendra Nayak, Srinivas Hebbar, Manjunath Shetty, Arul Amuthan

    Background: Psoriasis is a skin inflammation-based condition caused by immune dysfunction leading to physical, psychological and socio-economic burden. Limitations with the current treatments like cost, safety and variable patient outcomes have contributed to interest in exploration of herbal, traditional and complementary treatment approaches. Although the research area is expanding, no studies have been conducted regarding analysis of the trends in the field of herbal, traditional and complementary treatment approaches for psoriasis management. Main body: This study provides a comprehensive bibliometric evaluation of global output on these treatment approaches from the year 2005 to 2025. The publications were retrieved from the Scopus database following search strategy and 898 articles were included based on preselection criteria. The Bibliometrix R package and VOSviewer were the bibliometric tools used for the analysis of publications, geographical research institutions, authors, journal impact and thematic trends and evolution. The findings reveal increased productivity in the past decade, indicating research interest. China and India were leading contributors the field of research. Collaborative networks highlight international collaborations among European countries and the USA with Asian countries. Thematic evolution indicated the increasing research attention towards molecular mechanisms, immune and pro-inflammatory pathways, computational and bioinformatics approaches such as network pharmacology and molecular docking. The formulation advancements also emerged as new research interest in this research. Conclusion: Although the field demonstrated substantial progress, the literature mapped in this bibliometric analysis suggests that comparatively less emphasis on herbal standardization and clinical validation. Overall, the current analysis identifies the research progress, hotspots of research, and emphasize the significance of interdisciplinary research practices to strengthen scientific foundation of herbal therapeutics for psoriasis treatment.

  • Open Access

    Structure–property engineering of additively manufactured and 3D-printed polymeric biomaterials for chronic wound management

    by Deepanjan Datta, Maria Nison, Viola Colaco, Mahananda R. Prabhu, Sony Priyanka Bandi, Namdev Dhas, Srinivas Hebbar, Vasudev R Pai, Sudarshan Singh

    Chronic wounds, such as diabetic ulcers, pressure sores, and surgical incisions, may develop if the natural healing process is disrupted. Traditional approaches to managing chronic wounds require the involvement of a healthcare professional, although they do not guarantee patient adherence. The use of machine tooling in the design of wound healing products has provided effective solutions to this issue. In recent years, additive manufacturing has emerged as a versatile method that has garnered the attention of researchers and healthcare professionals. Additive manufacturing involves constructing intricate structures layer-by-layer using synthetic or natural polymers. Techniques such as stereolithography and micro-extrusion bioprinting have enabled the creation of diverse products that support wound healing. Furthermore, researchers are developing personalised wound healing therapies utilising advanced 3D printing technologies. The development of bioinks containing cells and therapeutics has greatly improved wound treatment and care. This progress is especially obvious in skin replacement engineering and regeneration. Printing methods enable the integration of bioactive chemicals and cells into polymers, scaffold designs, and individualised wound dressings, leading to faster healing. Overall, this extensive review covers recent advances in additive manufacturing and bioprinted polymeric biomaterials for chronic wound healing. Graphical abstract

  • Open Access

    Exploiting the role of milk extracellular vesicles: a comprehensive analysis on isolation methods, characterization, surface modifications, and their therapeutic applications

    by Mahananda R. Prabhu, Dinesh Upadhya, Harishkumar Madhyastha, Anup Naha, Haribalan Perumalsamy, Sneha Sunderraj, Akhilesh Dubey, Shadi Rahimi, Sri Renukadevi Balusamy, Srinivas Hebbar

    Milk EVs (MEVs) are a class of extracellular vesicles (EVs) that have attracted significant attention for their potential as natural nanocarriers in drug delivery. These nanosized vesicles (30 - 150 nm) are composed of a lipid bilayer that encapsulates proteins, nucleic acids, and lipids. The biogenesis of EVs involves a tightly regulated “endocytosis-fusion-secretion” pathway, and they are secreted by diverse cells into physiological fluids (blood, urine, and saliva). The isolation and characterization methods of MEVs are essential to achieve high purity, structural integrity, size distribution, and biomolecular composition. Efficient drug loading strategies such as passive diffusion, electroporation, and sonication enable the incorporation of therapeutic molecules. Surface modifications such as PEGylation, ligand conjugation, and genetic engineering further enhance the targeting efficiency, circulation stability, and therapeutic efficacy. Given their biocompatibility, low immunogenicity, and natural ability to traverse biological barriers, MEVs offer a scalable, and non-toxic platform for targeted drug delivery such as span cancer therapy, neurodegenerative disease treatment, and immune modulation. However, further research is needed to optimize MEV-based therapeutics, ensuring their efficacy and safety through rigorous clinical trials. This review explores the biogenesis, composition, isolation, characterization, drug-loading strategies, surface modifications, and therapeutic applications of MEVs, highlighting their emerging role in nanomedicine. Graphical abstract


  • Open Access

    Structured engineering of self-emulsifying drug delivery systems (SEDDS) via 3D printing: Comprehensive review

    by Induja Govindan, Anjana A. Kailas, K.A. Abutwaibe, Thamizharasan Annadurai, Ujwala Achar, Anup Naha, Srinivas Hebbar


  • Design and comparative evaluation of liposomes and ultra-flexible combisomes incorporating stratum corneum lipids for the delivery of 4-hydroxytamoxifen and thymoquinone

    by Pavithra Pradeep Prabhu, Cynthia Lizzie Lobo, Vishal L B, Mahananda R Prabhu, Srinivas Hebbar, Amina Sule Bendi, Ottah Daniel Chukwuemeka, Runde Musa, Khushwant S Yadav, Piyush Verma, et al.


  • Comprehensive Review of Solubility Parameters: Theoretical Foundations, Determination Methods, Pharmaceutical Applications, and Limitations

    by J. Thimmasetty, S. K. K. Shwetha, S. Sharda, N. N. Shashank, H. Srinivas, S. Bhishambar, D. Paramita

    Solubility parameters have long been utilized in the pharmaceutical industry though their application extends to other industries as well. Therefore, it has become a pivotal area in the research. This communication is a review of the applications of solubility parameters in pharmaceutical applications. In addition, A thorough description of the experimental and computational approaches—from conventional to modern—used to ascertain solubility parameters is also provided. Solubility parameters are primarily used to help choose suitable organic solvents or solvent blends, coformers for cocrystals, excipients, polymers, formulations containing lipids, solid dispersions, and drug delivery systems involving nanoparticles or microparticles. Interestingly, partial solubility parameters are thought to be very helpful for developing a drug delivery system for weakly soluble compounds, especially in the early phases of development when resources and compound obtainability are limited. Although the experimental find outs of solubility parameters can be time-consuming, it offers significant value, as the resulting data contribute to the ongoing enhancement of computational predictions. These advancements ensure that solubility parameters will continue to be an essential tool for scientists in identifying effective drug formulations in the future.


  • Open Access

    Demystifying multipronged approaches of wheat germ agglutinin-mediated drug delivery, targeting, and imaging: An explicative review

    by Mahananda R. Prabhu, Viola Colaco, Sony Priyanka Bandi, Srinivas Hebbar, Deepanjan Datta, Namdev Dhas, Sudarshan Singh, Harish Kumar Madhystha


  • Open Access

    Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy

    by Amitha Shetty, Akhilesh Dubey, Jeshma Chrystle, Manohar M, Anish John, Amitha N, Paramita Das, Srinivas Hebbar

    Background Curcumin, known for its anti-inflammatory properties, was selected for the developing consumer friendly film forming spray that offers precise delivery of curcumin and and improves patient adherence. Methods An optimized film-forming solution was prepared by dissolving curcumin (1%), Eudragit RLPO (5%), propylene glycol (1%), and camphor (0.5%) in ethanol: acetone (20:80) as the solvent. The solution was filled in a spray container which contained 70% solutions and 30% petroleum gas. In-vitro characterization was performed. Results Potential anti-inflammatory phytoconstituents were extracted from the PubChem database and prepared as ligands, along with receptor molecules (nsp10-nsp16), for molecular docking using Autodock Vina. The docking study showed the lowest binding energy of -8.2 kcal/mol indicates better binding affinities. The optimized formulation consisted of ethanol:acetone (20:80) as the solvent, Eudragit RLPO (5%) as the polymer, propylene glycol (1%) as the plasticizer, and camphor oil (0.5%) as the penetration enhancer. The optimized formulation exhibited pH of 5.8 ± 0.01, low viscosity, low film formation time (19.54 ± 0.78 sec), high drug content (8.243 ± 0.43 mg/mL), and extended ex vivo drug permeation (85.08 ± 0.09%) for nine hours. Consequently, the formulation was incorporated into a container using 30% liquefied petroleum gas, delivering 0.293 ± 0.08 mL per actuation, containing 1.53 ± 0.07 mg of the drug. The film-forming spray exhibited higher cumulative drug permeation (83.94 ± 0.34%) than the marketed cream formulation and pure drug solution after 9 h, with an enhancement ratio of 14. Notably, the film-forming spray exhibited no skin irritation and remained stable for over three months. Conclusions The developed curcumin film-forming system is promising as a carrier for wound management because of its convenient administration and transport attributes. Further in vivo studies are required to validate its efficacy in wound management.


  • Open Access

    Design and assessment of in silico screened diosmin incorporated ultra-flexible topical lipid gel system for the treatment of varicose vein

    by Akhilesh Dubey, Amitha Shetty, Chaithra R. Shetty, Namdev Dhas, Anup Naha, Pratika Bhandary, Srinivas Hebbar

    The ultra-flexible lipid gel system (UFLGS) consists of bilayer lipid membranes, responsible for highly elastic and deformable vesicles compared to conventional topical systems. Varicose veins are abnormal, dilated blood vessels resulting from weakening in the wall of the blood vessels. A flavonoid diosmin is highly potential to alleviate circulatory issues by altering blood veins’ elasticity and suppleness. Schrodinger 2023-1 suite device was used for molecular docking study. Ultra-flexible lipid nanosuspension (UFLNS) was developed and optimized. Then, they are characterized for Fourier transform infrared spectroscopy, differential scanning calorimetry, entrapment efficiency, transmission electron microscopy, atomic force microscopy, and turbidity measurement studies. After incorporating into the aqueous gelling agent Carbopol 934, Diosmin UFLGS (DUFLGS) was compared with the diosmin conventional gel system (DCGS) for its physicochemical properties. The docking score was –8.507, representing good interaction and binding affinity for nuclear factor-kappaB-inducing kinase. The particle size, polydispersity index, and surface charge of optimized diosmin-loaded UFLNS (DUFLNS) were found to be ideal values 144.56 ± 5.1 nm, 0.397 ± 0.13, and –24 ± 0.9 mV, respectively. The results of DUFLNS, DUFLGS, and DCGS showed skin retention values of 55.5% ± 13%, 83.44% ± 12%, and 66.39% ± 14%, respectively. The sustained release of the DUFLGS is owing to the elasticity of the ultra-flexible lipids, thereby the penetration enhanced compared to DCGS.


  • Open Access

    Advancing posaconazole quantification analysis with a new reverse-phase HPLC method in its bulk and marketed dosage form

    by Annamalai Rama, Induja Govindan, Srinivas Hebbar, Abhishek Chaturvedi, Usha Rani, Anup Naha

    Introduction: Posaconazole is a widely used antifungal drug, and its accurate quantification is essential for quality control and assessment of its pharmaceutical products. This study aimed to develop and validate a reverse-phase high-performance liquid chromatography (HPLC) analytical method for quantifying Posaconazole in bulk and dosage form. Methods: The HPLC method was developed and validated based on International Conference on Harmonisation (ICH) guidelines. The developed method was then applied to quantify Posaconazole in a marketed tablet formulation. The method's specificity, linearity, precision, accuracy, robustness, and stability were evaluated. Results: The developed HPLC method showed good linearity over a 2-20 μg/mL concentration range. The percentage recovery of Posaconazole from the bulk and marketed formulations was found to be 99.01% and 99.05%, respectively. The intra-day and inter-day precisions were less than 1%, and the method was stable under different conditions. The HPLC method was successfully applied to quantify Posaconazole in the marketed formulation. Conclusion: The developed and validated HPLC method is reliable and efficient for analyzing Posaconazole in bulk and dosage forms. The method's accuracy, precision, specificity, linearity, robustness, and stability demonstrate its effectiveness. The method can be used for the quality control and assessment of Posaconazole-containing pharmaceutical products.